Wolfe Research lowers Honeywell stock price target on aerospace weakness

Wolfe Research cut Honeywell's price target to $281 from $296 while keeping an Outperform rating, citing weaker aerospace margin expansion expectations and lower sector multiples. Honeywell's Q2 EPS guidance of $2.35-$2.45 missed Wolfe's $2.46 estimate and Street consensus of $2.56, with management also flagging a $100M-$150M Middle East headwind in Process and 90 bps of Q/Q margin contraction. The company reported Q1 EPS of $2.45 versus $2.32 expected, but revenue of $9.14B fell short of the $9.28B consensus, leaving a mixed but cautious setup ahead of the aerospace spinoff.

Analysis

The near-term setup is less about the headline earnings miss and more about a forced reset in expectations into a structural break-up. When a company is simultaneously absorbing stranded costs, issuing debt, and recasting guidance around a spin, reported margins become noisy enough that consensus typically over-penalizes the first 1-2 quarters and then has to re-rate once the cleaner post-spin earnings base becomes visible. That creates a tactical dislocation: the stock can stay weak even if underlying operations are stabilizing, because the market is pricing the accounting drag as if it were a permanent deterioration.

The bigger second-order issue is the aerospace bottleneck. If backlog is strong but production is constrained, the value capture shifts downstream to suppliers with actual capacity and away from the prime contractor until the line-rate inflects. That means HON’s own recovery may lag the broader aerospace cycle by multiple quarters, while peers with cleaner execution and less restructuring noise can keep compounding; the market will likely reward visible conversion of backlog into shipments more than backlog growth itself.

The Middle East cost hit matters most as a margin variability signal, not just a one-off dollar amount. It increases the probability that investors will assign a lower multiple to the Process and Automation mix until there is evidence the shock is transitory and not a recurring surcharge embedded in procurement or logistics. The key contrarian point is that the stock may already be discounting a worse long-run aerospace margin profile than is warranted; if production ramps into year-end and the spin removes the accounting overhang, the valuation gap could close faster than the street expects.

From a timing perspective, this is a months-not-days setup: downside can persist until the next guide/print, but the asymmetry improves into the June 29 separation and the first clean post-spin numbers. The main risk to being constructive is that execution slip extends another quarter, which would turn a temporary margin bridge into a credibility problem and force further estimate cuts. A sustained improvement in order-to-shipment conversion or any upward revision to aerospace production cadence would be the fastest catalyst to reverse the tape.

Key Decisions for Investors

• Avoid owning HON outright into the next guide revision; if already long, reduce exposure by 25-50% and wait for the post-spin accounting reset before re-engaging.
• Pair trade: long MMM or ETN vs short HON for the next 1-3 months, betting that cleaner industrial execution and less restructuring noise will out-earn HON while the market discounts stranded-cost drag.
• For tactical upside, buy HON Aug/Sep call spreads only after evidence of aerospace production inflection; risk/reward improves if the stock stabilizes near current levels and the market starts pricing cleaner 2026 numbers.
• If you want a relative value expression, go long aerospace suppliers with capacity leverage and short HON into the next 1-2 quarters; the backlog-to-revenue conversion trade should favor the names that can actually ship.
• Set an alert for the first post-spin full-year 2026 recast: if management narrows the aerospace margin bridge and removes uncertainty around stranded costs, that is the point to add back to HON on a 6-12 month horizon.